Archive: Raymond J. March
Raymond J. March is a Research Fellow at the Independent Institute.
FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression
Although much work remains to reverse the DEA’s overzealous scheduling system, Ketamine-based treatment for mental illness is another step in the right direction.
Healthcare Needs Price Competition, Not Just Transparency
Efforts to make healthcare costs more transparent are a good start. But transparency is no substitute for competition.
Competition is the Key to Reducing Insulin Prices
Not More Government Involvement
Evidence suggests that competition, not politicians, would provide the best chance to help diabetics obtain their life-prolonging medication.
Right-to-Try’s First Rescue
A Patient with Terminal Brain Cancer Gets Treatment
Signed into law in May, national right-to-try legislation allows patients with terminal illnesses to access experimental treatments with only the permission of their physicians and the drug provider.
If Teen Vaping Is Bad, the Alternative Is Worse
The FDA’s efforts to reduce teen vaping rates will likely result in worse health outcomes by prompting teens to switch to smoking cigarettes.
Evaporating Vaping Options
The FDA Moves to Regulate Away Consumer Choices
Stringent regulations on the e-cigarette market to come.
The FDA Loosens the Rules on Saving Lives
A Good Step, but Much More is Needed
To give the terminally ill the best chance, greater access to experimental medication is needed.
Telemedicine Is Popular: Why Isn’t It Everywhere?
Will telemedicine revolutionize the healthcare industry?
Telemedicine, the use of telecommunication technology to help administer medical care, is often credited with “radically changing” the healthcare market. Some have credited telemedicine with revolutionizing healthcare delivery, private practice, and outpatient care among other components of healthcare.
Medical Apps: Improving Healthcare on a Global Scale
Around 70% of all health problems can be handled online.
Wait times to see physicians have skyrocketed in recent years.
Right-to-Try Is Just What the Doctor Ordered
Right-to-Try opens new doors for terminally ill patients.
Those who defame right-to-try are quick to defend the FDA, insisting its current role protects consumers. Even in life-and-death situations, its opponents maintain should be made.